Delivery Order SPE2DB24D1006-SPE2DB25FCFAL
- Not listed
- The Defense Logistics Agency awarded a $2,321.58 delivery order to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets (quantity: 7 units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $68,576.46 delivery order to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets (seven-count units) under a firm fixed price contract. The contract was competitively awarded with no set-aside designation and includes an ultimate completion date of September 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,205.70 to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets (quantity 7) on April 29, 2025, with completion scheduled for April 30, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Orilissa is a prescription medication used in women's healthcare, reflecting the broad...
- The Defense Logistics Agency awarded a delivery order valued at $8,264.80 to AmerisourceBergen Drug Corp for Orilissa 150 mg tablets (7-count packages) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order is not set-aside and represents a non-competitive award to the established prime contractor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $7,530.90 to AmerisourceBergen Drug Corp for Orilissa 150 mg tablets (7-count packages) on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed price delivery order represents a non-competitive set-aside procurement and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was selected to supply this specialized...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets in quantities of 7 units, valued at $8,696.28. This firm fixed-price delivery order, which was not set-aside, was awarded on July 23, 2025, with an ultimate completion date of July 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 4569155062, Orilissa 150 mg tablets (quantity 7), valued at $10,086.63 under a firm fixed price contract type. The award was made on August 20, 2025, with an ultimate completion date of August 21, 2025. No set-aside designation was used for this competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of the medication Orilissa (Elagolix) 150 mg tablets. The contract has a ceiling value of $3,418.68 and a completion date of October 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- The Defense Logistics Agency awarded a $3,779.34 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for 14 tablets of the 200mg Orilissa drug. The order is for product delivery to a location in Conshohocken, Pennsylvania by October 12, 2023. No set-aside designation was applied to this order, which is being fulfilled under the parent company Amerisourcebergen's corporate office. The Defense Logistics Agency functions include procuring...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the medication Orilissa 150 mg tablet. The contract has a ceiling value of $3,029.17 and an ultimate completion date of February 14, 2022. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is...
- SPE2DB24D1006Indefinite Delivery Contract
- SPE2DB24D1006-SPE2DB25FCFALDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Orilissa 200 mg tablets (14-count packaging) with a ceiling value of $8,559.49 under a firm fixed-price contract. This non-set-aside award was competitively procured and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies comprehensive medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse pharmaceutical procurement requirements, ranging from specialty medications and vaccines to brand-name and generic drugs across multiple therapeutic domains. This delivery order for Orilissa, an endometriosis treatment, reflects the company's ongoing role in supporting military and veteran healthcare supply chains through the DLA's global pharmaceutical support framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 8/18/25 |